HUP0401978A2 - Tamszulozintabletták - Google Patents

Tamszulozintabletták

Info

Publication number
HUP0401978A2
HUP0401978A2 HU0401978A HUP0401978A HUP0401978A2 HU P0401978 A2 HUP0401978 A2 HU P0401978A2 HU 0401978 A HU0401978 A HU 0401978A HU P0401978 A HUP0401978 A HU P0401978A HU P0401978 A2 HUP0401978 A2 HU P0401978A2
Authority
HU
Hungary
Prior art keywords
tablet
tamsulosin
tamsulosin tablets
tablets
subject
Prior art date
Application number
HU0401978A
Other languages
English (en)
Inventor
Johannes Jan Platteeuw
Frans Dalen
Jacobus Maria Lemmens
Original Assignee
Synthon B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23292437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0401978(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthon B.V. filed Critical Synthon B.V.
Publication of HUP0401978A2 publication Critical patent/HUP0401978A2/hu
Publication of HUP0401978A3 publication Critical patent/HUP0401978A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

A találmány tárgya olyan gyógyszertabletta, amely folyadék alkalmazásanélküli eljárással állítható elő és a tabletta 0,1-1,5% tamszulozinhatóanyagot és legalább egy gyógyászatilag elfogadható segédanyagottartalmaz. A tabletta jóindulatú prosztata-hiperplázia kezelésérealkalmazható. Ó
HU0401978A 2001-11-07 2002-11-01 Tamsulosin tablets HUP0401978A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33105501P 2001-11-07 2001-11-07
PCT/NL2002/000695 WO2003039530A1 (en) 2001-11-07 2002-11-01 Tamsulosin tablets

Publications (2)

Publication Number Publication Date
HUP0401978A2 true HUP0401978A2 (hu) 2005-01-28
HUP0401978A3 HUP0401978A3 (en) 2008-07-28

Family

ID=23292437

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0401978A HUP0401978A3 (en) 2001-11-07 2002-11-01 Tamsulosin tablets
HU0402004A HU230830B1 (hu) 2001-11-07 2002-11-06 Módosított hatóanyag-leadású tamszulozin tabletták

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0402004A HU230830B1 (hu) 2001-11-07 2002-11-06 Módosított hatóanyag-leadású tamszulozin tabletták

Country Status (21)

Country Link
US (2) US20030147950A1 (hu)
EP (3) EP1443917B1 (hu)
JP (3) JP2005512997A (hu)
CN (3) CN1298317C (hu)
AT (3) ATE321544T1 (hu)
AU (1) AU2002301845B2 (hu)
CA (2) CA2465110A1 (hu)
CZ (3) CZ16814U1 (hu)
DE (4) DE20220415U1 (hu)
DK (3) DK1443917T3 (hu)
ES (2) ES2256544T3 (hu)
HU (2) HUP0401978A3 (hu)
IL (4) IL161491A0 (hu)
NL (2) NL1021822C2 (hu)
NO (2) NO20042374L (hu)
NZ (2) NZ532589A (hu)
PT (2) PT1443917E (hu)
RU (2) RU2311903C2 (hu)
SI (2) SI1443917T1 (hu)
WO (2) WO2003039530A1 (hu)
ZA (2) ZA200403281B (hu)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200403281B (en) * 2001-11-07 2005-12-13 Synthon Bv Tamsulosin tablets.
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
IN192381B (hu) * 2002-12-20 2004-04-10 Ranbaxy Lab
US20040253309A1 (en) * 2003-01-27 2004-12-16 Yamanouchi Pharmaceutical Co., Ltd. Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
WO2005004851A1 (en) * 2003-07-01 2005-01-20 Krka, Tovarna Zdravil, D.D. Novo Mesto Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate
EP1673073A4 (en) * 2003-09-29 2012-03-21 Cj Cheiljedang Corp SLOW RELEASE FORMULATIONS
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
WO2005053659A1 (en) * 2003-12-03 2005-06-16 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
JP4603803B2 (ja) * 2004-01-30 2010-12-22 大洋薬品工業株式会社 放出制御医薬組成物およびこれを用いる製剤
PL204079B1 (pl) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
BRPI0518396A2 (pt) 2004-12-27 2008-11-18 Eisai R&D Man Co Ltd mÉtodo para estabilizaÇço de droga anti-demÊncia
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
KR100678421B1 (ko) * 2005-02-11 2007-02-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
BRPI0608780A2 (pt) * 2005-04-28 2010-11-09 Eisai R&D Man Co Ltd composição contendo fármaco anti-demência
CN1895241B (zh) * 2005-07-12 2010-05-12 可隆制药株式会社 盐酸坦洛新的口服长效性小药丸组成物及其制造方法
WO2007017253A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung eines benzolsulfonamids
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
EP2026766A1 (en) * 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (en) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Controlled release tamsulosin hydrochloride tablets and a process of making them
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2554168B1 (en) 2010-03-29 2018-01-24 Astellas Pharma Inc. Controlled release pharmaceutical composition
ES2723029T3 (es) 2010-04-30 2019-08-21 Takeda Pharmaceuticals Co Tableta entérica
SG10201505503WA (en) * 2011-05-25 2015-09-29 Taiho Pharmaceutical Co Ltd Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (zh) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 一种含有盐酸坦索罗辛的缓释制剂及其制备方法
WO2017186598A1 (en) 2016-04-25 2017-11-02 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3292864A1 (en) 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron
US10478399B2 (en) 2017-10-12 2019-11-19 Synthon B.V. Modified release tablet composition comprising mirabegron
WO2019072404A1 (en) 2017-10-12 2019-04-18 Synthon B.V. MODIFIED RELEASE COMPRESSED COMPOSITION COMPRISING MIRABEGRON
EP4035660A1 (en) 2017-10-17 2022-08-03 Synthon B.V. Tablets comprising tamsulosin and solifenacin

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
WO1994009785A2 (en) * 1992-11-04 1994-05-11 Sepracor, Inc. Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
AU7085194A (en) * 1993-07-14 1995-02-13 Yamanouchi Pharmaceutical Co., Ltd. Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (ja) * 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (ja) * 1998-06-26 2000-03-21 Yamanouchi Pharmaceut Co Ltd 排出障害治療剤
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
NZ514890A (en) * 1999-03-31 2003-05-30 Janssen Pharmaceutica Nv Pregelatinized starch in a controlled release formulation
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
ID30249A (id) * 1999-08-09 2001-11-15 Yamanouchi Pharma Co Ltd Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
CA2419089A1 (en) * 2001-07-27 2003-03-05 Tatsuki Shinoda Composition comprises sustained-release fine particles for quick-disintegrating tablets in the buccal cavity and manufacturing method thereof
ZA200403281B (en) † 2001-11-07 2005-12-13 Synthon Bv Tamsulosin tablets.

Also Published As

Publication number Publication date
EP1441713B1 (en) 2007-08-08
EP1441713A1 (en) 2004-08-04
HUP0402004A3 (en) 2008-08-28
ES2287333T3 (es) 2007-12-16
AT9978U1 (de) 2008-07-15
ZA200403281B (en) 2005-12-13
CA2464689A1 (en) 2003-05-15
PT1443917E (pt) 2006-06-30
NL1021822C2 (nl) 2003-07-15
DE20220415U1 (de) 2003-10-09
NZ532589A (en) 2005-02-25
JP5536610B2 (ja) 2014-07-02
ES2287333T5 (es) 2019-04-29
JP2011051995A (ja) 2011-03-17
CN1298317C (zh) 2007-02-07
EP1595538A3 (en) 2006-02-22
NZ532592A (en) 2005-02-25
HUP0401978A3 (en) 2008-07-28
HUP0402004A2 (hu) 2005-01-28
IL161525A (en) 2012-12-31
NL1021822A1 (nl) 2003-05-08
NL1021857A1 (nl) 2003-05-08
IL161491A0 (en) 2004-09-27
WO2003039531A1 (en) 2003-05-15
NL1021857C2 (nl) 2004-01-09
DK1441713T4 (en) 2019-02-18
DE60221691T2 (de) 2008-04-30
EP1595538A2 (en) 2005-11-16
CN1652760A (zh) 2005-08-10
ES2256544T3 (es) 2006-07-16
SI1441713T1 (sl) 2007-10-31
PT1441713E (pt) 2007-08-28
DK1441713T3 (da) 2007-12-17
DE60221691T3 (de) 2019-04-04
CZ16814U1 (cs) 2006-08-28
ATE321544T1 (de) 2006-04-15
HU230830B1 (hu) 2018-07-30
JP2005511591A (ja) 2005-04-28
US20030147950A1 (en) 2003-08-07
CA2464689C (en) 2011-02-01
NO20042375L (no) 2004-08-09
EP1443917A1 (en) 2004-08-11
CN1589139A (zh) 2005-03-02
DE60221691D1 (de) 2007-09-20
ATE369128T2 (de) 2007-08-15
AU2002301845B2 (en) 2008-06-05
JP2005512997A (ja) 2005-05-12
RU2335280C2 (ru) 2008-10-10
IL161525A0 (en) 2004-09-27
CZ16813U1 (cs) 2006-08-28
DK1443917T3 (da) 2006-07-17
ZA200403430B (en) 2006-02-22
WO2003039530A1 (en) 2003-05-15
RU2004117081A (ru) 2005-03-20
DE60210315D1 (de) 2006-05-18
US20030147955A1 (en) 2003-08-07
SI1443917T1 (sl) 2006-06-30
NO20042374L (no) 2004-08-09
NO340960B1 (no) 2017-07-31
CZ16809U1 (cs) 2006-08-28
CA2465110A1 (en) 2003-05-15
DE60210315T2 (de) 2006-11-02
IL161491A (en) 2009-07-20
RU2004117080A (ru) 2005-04-10
EP1441713B2 (en) 2018-11-14
SI1441713T2 (sl) 2019-03-29
RU2311903C2 (ru) 2007-12-10
DK200500297U3 (da) 2006-03-10
CN102327250A (zh) 2012-01-25
DE20221486U1 (de) 2006-02-02
EP1443917B1 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
HUP0401978A2 (hu) Tamszulozintabletták
HUP0400689A2 (hu) ABCA-1 szint-emelő vegyületek
HUP0002316A2 (hu) Gyorsan olvadó orális adagolási formák
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
HUP0300426A2 (hu) Antihipertenzív és anti-angiogén szerek terápiás kombinációja és ezeket tartalmazó gyógyszerkészítmények
BR9908438A (pt) Tabletes de desintegração rápida
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0202862A2 (hu) A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény
HUP0300061A2 (hu) IL-18 inhibitorok alkalmazása
MY127350A (en) Flash-melt oral dose formulations
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HUP0402304A2 (hu) Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények
HUP0300559A2 (hu) A trombopoietin receptort moduláló peptidek
HUP0400553A2 (hu) Gyógyászati készítmények
SE9700885D0 (sv) New pharmaceutical formulation
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees